The Latest Breaking News from Pfizer

The Therapeutic Goods Administration has approved the Pfizer COVID booster for people aged 12 to 15, but it will need a final tick of approval before it is made available to the cohort.

Egypt has received 1.5 million doses of Pfizer’s coronavirus vaccine donated by the US government. Acting Health Minister Khaled Abdel Ghaffar said Egypt received 1,501,110 Pfizer COVID-19 vaccine doses gifted by the US and delivered through the COVAX initiative and in cooperation with the Vaccine Alliance (GAVI). The new batch…

Here's a roundup of top developments in the biotech space over the last 24 hours:

The Omicron variant and and anti-vaccine backlash are complicating the effort.

A fourth shot of the Pfizer COVID-19 vaccine increased protection against viral infection for only four to seven weeks, according to a massive study published Tuesday.

Exclusive: Sadiq Khan, alongside mayors of New York and Johannesburg, urged companies ‘to do all you can’ to promote vaccine equity and ‘help stop the unnecessary loss of life’

An Israel-based study has found that a fourth dose of the Pfizer Inc (NYSE: PFE) / BioNTech SE (NASDAQ: BNTX) vaccine lowered rates of COVID-19 infection among the elderly.

EU health agencies said on Wednesday there was no evidence to support the use of a fourth dose of COVID-19 vaccines developed by Pfizer and Moderna in the general population, but they recommend a second booster for people aged 80 and above. There is no clear evidence in the European…

Vaccine stocks toppled Wednesday after an Israeli study suggested immunity wanes quickly following a second Covid booster shot.